カテゴリー： QYResearch, 世界

世界の軸性脊椎関節炎薬市場

◆英語タイトル：Global Axial Spondyloarthritis Drugs Market Professional Survey Report 2019
◆商品コード：DATA909X04293
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月15日（※2024年版があります。お問い合わせください）
◆ページ数：108
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、軸性脊椎関節炎薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、セルトリズマブペゴル、エタネルセプトバイオシミラー、イキセキズマブ、セキヌマブ、その他に、用途別には、クリニック、病院、ホームケアにセグメント区分し、軸性脊椎関節炎薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・軸性脊椎関節炎薬の世界市場概要
・軸性脊椎関節炎薬の製造コスト構成分析
・軸性脊椎関節炎薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・軸性脊椎関節炎薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・軸性脊椎関節炎薬のセグメント分析（種類別）
（セルトリズマブペゴル、エタネルセプトバイオシミラー、イキセキズマブ、セキヌマブ、その他）
・軸性脊椎関節炎薬のセグメント分析（用途別）
（クリニック、病院、ホームケア）
・軸性脊椎関節炎薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（AstraZeneca Plc、Eli Lilly and Company、Johnson & Johnson、Novartis AG、Panacea Biotec Ltd、Sandoz International GmbH、Sun Pharma Advanced Research Company Ltd、UCB SA、）
・軸性脊椎関節炎薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Axial Spondyloarthritis Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Axial Spondyloarthritis Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Axial Spondyloarthritis Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Axial Spondyloarthritis Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Axial Spondyloarthritis Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AstraZeneca Plc
Eli Lilly and Company
Johnson & Johnson
Novartis AG
Panacea Biotec Ltd
Sandoz International GmbH
Sun Pharma Advanced Research Company Ltd
UCB SA

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Certolizumab Pegol
Etanercept Biosimilar
Ixekizumab
Secukinumab
Others

Segment by Application
Clinic
Hospital
Home Care

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Axial Spondyloarthritis Drugs
1.1 Definition of Axial Spondyloarthritis Drugs
1.2 Axial Spondyloarthritis Drugs Segment by Type
1.2.1 Global Axial Spondyloarthritis Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Certolizumab Pegol
1.2.3 Etanercept Biosimilar
1.2.4 Ixekizumab
1.2.5 Secukinumab
1.2.6 Others
1.3 Axial Spondyloarthritis Drugs Segment by Applications
1.3.1 Global Axial Spondyloarthritis Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Home Care
1.4 Global Axial Spondyloarthritis Drugs Overall Market
1.4.1 Global Axial Spondyloarthritis Drugs Revenue (2014-2025)
1.4.2 Global Axial Spondyloarthritis Drugs Production (2014-2025)
1.4.3 North America Axial Spondyloarthritis Drugs Status and Prospect (2014-2025)
1.4.4 Europe Axial Spondyloarthritis Drugs Status and Prospect (2014-2025)
1.4.5 China Axial Spondyloarthritis Drugs Status and Prospect (2014-2025)
1.4.6 Japan Axial Spondyloarthritis Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Axial Spondyloarthritis Drugs Status and Prospect (2014-2025)
1.4.8 India Axial Spondyloarthritis Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Axial Spondyloarthritis Drugs
2.3 Manufacturing Process Analysis of Axial Spondyloarthritis Drugs
2.4 Industry Chain Structure of Axial Spondyloarthritis Drugs

3 Development and Manufacturing Plants Analysis of Axial Spondyloarthritis Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Axial Spondyloarthritis Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Axial Spondyloarthritis Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Axial Spondyloarthritis Drugs Production and Capacity Analysis
4.2 Axial Spondyloarthritis Drugs Revenue Analysis
4.3 Axial Spondyloarthritis Drugs Price Analysis
4.4 Market Concentration Degree

5 Axial Spondyloarthritis Drugs Regional Market Analysis
5.1 Axial Spondyloarthritis Drugs Production by Regions
5.1.1 Global Axial Spondyloarthritis Drugs Production by Regions
5.1.2 Global Axial Spondyloarthritis Drugs Revenue by Regions
5.2 Axial Spondyloarthritis Drugs Consumption by Regions
5.3 North America Axial Spondyloarthritis Drugs Market Analysis
5.3.1 North America Axial Spondyloarthritis Drugs Production
5.3.2 North America Axial Spondyloarthritis Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Axial Spondyloarthritis Drugs Import and Export
5.4 Europe Axial Spondyloarthritis Drugs Market Analysis
5.4.1 Europe Axial Spondyloarthritis Drugs Production
5.4.2 Europe Axial Spondyloarthritis Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Axial Spondyloarthritis Drugs Import and Export
5.5 China Axial Spondyloarthritis Drugs Market Analysis
5.5.1 China Axial Spondyloarthritis Drugs Production
5.5.2 China Axial Spondyloarthritis Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Axial Spondyloarthritis Drugs Import and Export
5.6 Japan Axial Spondyloarthritis Drugs Market Analysis
5.6.1 Japan Axial Spondyloarthritis Drugs Production
5.6.2 Japan Axial Spondyloarthritis Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Axial Spondyloarthritis Drugs Import and Export
5.7 Southeast Asia Axial Spondyloarthritis Drugs Market Analysis
5.7.1 Southeast Asia Axial Spondyloarthritis Drugs Production
5.7.2 Southeast Asia Axial Spondyloarthritis Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Axial Spondyloarthritis Drugs Import and Export
5.8 India Axial Spondyloarthritis Drugs Market Analysis
5.8.1 India Axial Spondyloarthritis Drugs Production
5.8.2 India Axial Spondyloarthritis Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Axial Spondyloarthritis Drugs Import and Export

6 Axial Spondyloarthritis Drugs Segment Market Analysis (by Type)
6.1 Global Axial Spondyloarthritis Drugs Production by Type
6.2 Global Axial Spondyloarthritis Drugs Revenue by Type
6.3 Axial Spondyloarthritis Drugs Price by Type

7 Axial Spondyloarthritis Drugs Segment Market Analysis (by Application)
7.1 Global Axial Spondyloarthritis Drugs Consumption by Application
7.2 Global Axial Spondyloarthritis Drugs Consumption Market Share by Application (2014-2019)

8 Axial Spondyloarthritis Drugs Major Manufacturers Analysis
8.1 AstraZeneca Plc
8.1.1 AstraZeneca Plc Axial Spondyloarthritis Drugs Production Sites and Area Served
8.1.2 AstraZeneca Plc Product Introduction, Application and Specification
8.1.3 AstraZeneca Plc Axial Spondyloarthritis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Eli Lilly and Company
8.2.1 Eli Lilly and Company Axial Spondyloarthritis Drugs Production Sites and Area Served
8.2.2 Eli Lilly and Company Product Introduction, Application and Specification
8.2.3 Eli Lilly and Company Axial Spondyloarthritis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Johnson & Johnson
8.3.1 Johnson & Johnson Axial Spondyloarthritis Drugs Production Sites and Area Served
8.3.2 Johnson & Johnson Product Introduction, Application and Specification
8.3.3 Johnson & Johnson Axial Spondyloarthritis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Novartis AG
8.4.1 Novartis AG Axial Spondyloarthritis Drugs Production Sites and Area Served
8.4.2 Novartis AG Product Introduction, Application and Specification
8.4.3 Novartis AG Axial Spondyloarthritis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Panacea Biotec Ltd
8.5.1 Panacea Biotec Ltd Axial Spondyloarthritis Drugs Production Sites and Area Served
8.5.2 Panacea Biotec Ltd Product Introduction, Application and Specification
8.5.3 Panacea Biotec Ltd Axial Spondyloarthritis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Sandoz International GmbH
8.6.1 Sandoz International GmbH Axial Spondyloarthritis Drugs Production Sites and Area Served
8.6.2 Sandoz International GmbH Product Introduction, Application and Specification
8.6.3 Sandoz International GmbH Axial Spondyloarthritis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Sun Pharma Advanced Research Company Ltd
8.7.1 Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Production Sites and Area Served
8.7.2 Sun Pharma Advanced Research Company Ltd Product Introduction, Application and Specification
8.7.3 Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 UCB SA
8.8.1 UCB SA Axial Spondyloarthritis Drugs Production Sites and Area Served
8.8.2 UCB SA Product Introduction, Application and Specification
8.8.3 UCB SA Axial Spondyloarthritis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Axial Spondyloarthritis Drugs Market
9.1 Global Axial Spondyloarthritis Drugs Market Trend Analysis
9.1.1 Global Axial Spondyloarthritis Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Axial Spondyloarthritis Drugs Regional Market Trend
9.2.1 North America Axial Spondyloarthritis Drugs Forecast 2019-2025
9.2.2 Europe Axial Spondyloarthritis Drugs Forecast 2019-2025
9.2.3 China Axial Spondyloarthritis Drugs Forecast 2019-2025
9.2.4 Japan Axial Spondyloarthritis Drugs Forecast 2019-2025
9.2.5 Southeast Asia Axial Spondyloarthritis Drugs Forecast 2019-2025
9.2.6 India Axial Spondyloarthritis Drugs Forecast 2019-2025
9.3 Axial Spondyloarthritis Drugs Market Trend (Product Type)
9.4 Axial Spondyloarthritis Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Axial Spondyloarthritis Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Axial Spondyloarthritis Drugs
Table Global Axial Spondyloarthritis Drugs Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Axial Spondyloarthritis Drugs Production Market Share by Types in 2018
Figure Certolizumab Pegol Product Picture
Figure Etanercept Biosimilar Product Picture
Figure Ixekizumab Product Picture
Figure Secukinumab Product Picture
Figure Others Product Picture
Table Global Axial Spondyloarthritis Drugs Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Axial Spondyloarthritis Drugs Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Home Care
Figure Global Axial Spondyloarthritis Drugs Revenue (Million USD) (2014-2025)
Figure Global Axial Spondyloarthritis Drugs Production (K Pcs) (2014-2025)
Figure North America Axial Spondyloarthritis Drugs Market Size (Million USD) (2014-2025)
Figure Europe Axial Spondyloarthritis Drugs Market Size (Million USD) (2014-2025)
Figure China Axial Spondyloarthritis Drugs Market Size (Million USD) (2014-2025)
Figure Japan Axial Spondyloarthritis Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Axial Spondyloarthritis Drugs Market Size (Million USD) (2014-2025)
Figure India Axial Spondyloarthritis Drugs Market Size (Million USD) (2014-2025)
Table Axial Spondyloarthritis Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Axial Spondyloarthritis Drugs in 2018
Figure Manufacturing Process Analysis of Axial Spondyloarthritis Drugs
Figure Industry Chain Structure of Axial Spondyloarthritis Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Axial Spondyloarthritis Drugs Manufacturing Plants Distribution
Table Axial Spondyloarthritis Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Axial Spondyloarthritis Drugs Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Axial Spondyloarthritis Drugs Production (K Pcs) of Major Manufacturers (2014-2019)
Table Axial Spondyloarthritis Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Axial Spondyloarthritis Drugs Production Share by Manufacturers in 2018
Table Axial Spondyloarthritis Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Axial Spondyloarthritis Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Axial Spondyloarthritis Drugs Revenue Share by Manufacturers in 2018
Table Axial Spondyloarthritis Drugs Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Axial Spondyloarthritis Drugs Production by Regions 2014-2019 (K Pcs)
Table Global Axial Spondyloarthritis Drugs Production Market Share by Regions 2014-2019
Figure Global Axial Spondyloarthritis Drugs Production Market Share by Regions in 2018
Table Global Axial Spondyloarthritis Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Axial Spondyloarthritis Drugs Revenue Market Share by Regions 2014-2019
Figure Global Axial Spondyloarthritis Drugs Revenue Market Share by Regions in 2018
Table Global Axial Spondyloarthritis Drugs Consumption by Regions 2014-2019 (K Pcs)
Table Global Axial Spondyloarthritis Drugs Consumption Market Share by Regions 2014-2019
Figure North America Axial Spondyloarthritis Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure North America Axial Spondyloarthritis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Axial Spondyloarthritis Drugs Production, Consumption Import and Export (K Pcs)
Figure Europe Axial Spondyloarthritis Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Axial Spondyloarthritis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Axial Spondyloarthritis Drugs Production, Consumption Import and Export (K Pcs)
Figure China Axial Spondyloarthritis Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure China Axial Spondyloarthritis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Axial Spondyloarthritis Drugs Production, Consumption Import and Export (K Pcs)
Figure Japan Axial Spondyloarthritis Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Axial Spondyloarthritis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Axial Spondyloarthritis Drugs Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Axial Spondyloarthritis Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Axial Spondyloarthritis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Axial Spondyloarthritis Drugs Production, Consumption Import and Export (K Pcs)
Figure India Axial Spondyloarthritis Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure India Axial Spondyloarthritis Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Axial Spondyloarthritis Drugs Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Axial Spondyloarthritis Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Axial Spondyloarthritis Drugs Market Share by Application (2014-2019)
Table AstraZeneca Plc Axial Spondyloarthritis Drugs Production Sites and Area Served
Table AstraZeneca Plc Axial Spondyloarthritis Drugs Product Introduction, Application and Specification
Table AstraZeneca Plc Axial Spondyloarthritis Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AstraZeneca Plc Axial Spondyloarthritis Drugs Production Growth Rate (2014-2019)
Table AstraZeneca Plc Axial Spondyloarthritis Drugs Production Market Share (2014-2019)
Figure AstraZeneca Plc Axial Spondyloarthritis Drugs Revenue Market Share (2014-2019)
Table AstraZeneca Plc Axial Spondyloarthritis Drugs Main Business and Markets Served
Table Eli Lilly and Company Axial Spondyloarthritis Drugs Production Sites and Area Served
Table Eli Lilly and Company Axial Spondyloarthritis Drugs Product Introduction, Application and Specification
Table Eli Lilly and Company Axial Spondyloarthritis Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly and Company Axial Spondyloarthritis Drugs Production Growth Rate (2014-2019)
Table Eli Lilly and Company Axial Spondyloarthritis Drugs Production Market Share (2014-2019)
Figure Eli Lilly and Company Axial Spondyloarthritis Drugs Revenue Market Share (2014-2019)
Table Eli Lilly and Company Axial Spondyloarthritis Drugs Main Business and Markets Served
Table Johnson & Johnson Axial Spondyloarthritis Drugs Production Sites and Area Served
Table Johnson & Johnson Axial Spondyloarthritis Drugs Product Introduction, Application and Specification
Table Johnson & Johnson Axial Spondyloarthritis Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson Axial Spondyloarthritis Drugs Production Growth Rate (2014-2019)
Table Johnson & Johnson Axial Spondyloarthritis Drugs Production Market Share (2014-2019)
Figure Johnson & Johnson Axial Spondyloarthritis Drugs Revenue Market Share (2014-2019)
Table Johnson & Johnson Axial Spondyloarthritis Drugs Main Business and Markets Served
Table Novartis AG Axial Spondyloarthritis Drugs Production Sites and Area Served
Table Novartis AG Axial Spondyloarthritis Drugs Product Introduction, Application and Specification
Table Novartis AG Axial Spondyloarthritis Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG Axial Spondyloarthritis Drugs Production Growth Rate (2014-2019)
Table Novartis AG Axial Spondyloarthritis Drugs Production Market Share (2014-2019)
Figure Novartis AG Axial Spondyloarthritis Drugs Revenue Market Share (2014-2019)
Table Novartis AG Axial Spondyloarthritis Drugs Main Business and Markets Served
Table Panacea Biotec Ltd Axial Spondyloarthritis Drugs Production Sites and Area Served
Table Panacea Biotec Ltd Axial Spondyloarthritis Drugs Product Introduction, Application and Specification
Table Panacea Biotec Ltd Axial Spondyloarthritis Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Panacea Biotec Ltd Axial Spondyloarthritis Drugs Production Growth Rate (2014-2019)
Table Panacea Biotec Ltd Axial Spondyloarthritis Drugs Production Market Share (2014-2019)
Figure Panacea Biotec Ltd Axial Spondyloarthritis Drugs Revenue Market Share (2014-2019)
Table Panacea Biotec Ltd Axial Spondyloarthritis Drugs Main Business and Markets Served
Table Sandoz International GmbH Axial Spondyloarthritis Drugs Production Sites and Area Served
Table Sandoz International GmbH Axial Spondyloarthritis Drugs Product Introduction, Application and Specification
Table Sandoz International GmbH Axial Spondyloarthritis Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sandoz International GmbH Axial Spondyloarthritis Drugs Production Growth Rate (2014-2019)
Table Sandoz International GmbH Axial Spondyloarthritis Drugs Production Market Share (2014-2019)
Figure Sandoz International GmbH Axial Spondyloarthritis Drugs Revenue Market Share (2014-2019)
Table Sandoz International GmbH Axial Spondyloarthritis Drugs Main Business and Markets Served
Table Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Production Sites and Area Served
Table Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Product Introduction, Application and Specification
Table Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Production Growth Rate (2014-2019)
Table Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Production Market Share (2014-2019)
Figure Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Revenue Market Share (2014-2019)
Table Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Main Business and Markets Served
Table UCB SA Axial Spondyloarthritis Drugs Production Sites and Area Served
Table UCB SA Axial Spondyloarthritis Drugs Product Introduction, Application and Specification
Table UCB SA Axial Spondyloarthritis Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table UCB SA Axial Spondyloarthritis Drugs Production Growth Rate (2014-2019)
Table UCB SA Axial Spondyloarthritis Drugs Production Market Share (2014-2019)
Figure UCB SA Axial Spondyloarthritis Drugs Revenue Market Share (2014-2019)
Table UCB SA Axial Spondyloarthritis Drugs Main Business and Markets Served
Figure Global Axial Spondyloarthritis Drugs Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Axial Spondyloarthritis Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Axial Spondyloarthritis Drugs Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Axial Spondyloarthritis Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Axial Spondyloarthritis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Axial Spondyloarthritis Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Axial Spondyloarthritis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Axial Spondyloarthritis Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Axial Spondyloarthritis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Axial Spondyloarthritis Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Axial Spondyloarthritis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Axial Spondyloarthritis Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Axial Spondyloarthritis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Axial Spondyloarthritis Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Axial Spondyloarthritis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Axial Spondyloarthritis Drugs by Type (2019-2025)
Table Global Consumption (K Pcs) of Axial Spondyloarthritis Drugs by Application (2019-2025)
Table Axial Spondyloarthritis Drugs Distributors List
Table Axial Spondyloarthritis Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

AstraZeneca Plc、Eli Lilly and Company、Johnson & Johnson、Novartis AG、Panacea Biotec Ltd、Sandoz International GmbH、Sun Pharma Advanced Research Company Ltd、UCB SA、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の軸性脊椎関節炎薬市場(Global Axial Spondyloarthritis Drugs Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp